General MedicationsSINGLE-USEStandard
KITPROZY
CARFILZOMIB
Standard Dose
120MG/2ML (60MG/ML), 2ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview KITPROZY is listed in Drugs@FDA under application 220712 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CARFILZOMIB Form and strength VIAL; SINGLE-USE - 120MG/2ML (60MG/ML), 2ML Sponsor AMNEAL PHARMS NY Submission history Latest submission status date: 2026-03-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview KITPROZY is listed in Drugs@FDA under application 220712 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CARFILZOMIB Form and strength VIAL; SINGLE-USE - 120MG/2ML (60MG/ML), 2ML Sponsor AMNEAL PHARMS NY Submission history Latest submission status date: 2026-03-19 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.